Canada: Canadian Courts Take A Pro-Patentee Stance In Respect Of Granting Interim Or Interlocutory Injunctions

Last Updated: May 30 2019
Article by Pia-Lauren Reece

It is well accepted that patentees looking to obtain interlocutory or interim injunctions against alleged infringers have a tough road ahead of them since the granting of such relief by Canadian courts has been very uncommon. However, it is not impossible as both a provincial and a federal court have recently decided in favour of granting the relief.

Within a year of a provincial court granting an interlocutory injunction in Thermolec ltée c. Stelpro Design Inc., 2018 QCCS 901, the Federal Court of Canada has granted the application for an interim injunction to Arysta Lifescience North America LLC and UPL Agrosolutions Canada Inc. ("Arysta") against AgraCity Crop & Nutrition Ltd. And NewAgco Inc. ("AgraCity") in Arysta LifeScience North America et al v. AgraCity Crop et al, 2019 FC 530.

In this case, Arysta sought an interim injunction to prevent AgraCity from selling and distributing a herbicide which Arysta claims infringes its patent. As part of the claim and requirement for obtaining the interim injunction, Arysta also claimed that the matter is urgent because the peak season for selling and distributing this type of herbicide is now, just prior to the planting season.

The legal test for interim or interlocutory injunctions is a difficult one, requiring that the plaintiff satisfy three criteria: (1) that there is a "serious question to be tried"; (2) that the plaintiff will suffer irreparable harm if an injunction is refused; and (3) that the balance of convenience favours granting the injunction to the plaintiff. It is typically the irreparable harm hurdle that is the most challenging criterion to satisfy, since it is generally believed that the harm caused by the infringement can be quantified and repaired by the awarding of damages. In claiming irreparable damages, the plaintiff needs to provide "clear, convincing, and non-speculative evidence that such harm will be caused by the infringement" [21].

The patent at issue was Canadian Patent No. 2,346,021 directed to a selective herbicide composition of flucarbazone sodium (70% by weight water dispersible powder or granule) and its use. With AgraCity recently receiving approval of a generic version of Arysta's granular herbicide and given the similarity between the two products, the first prong of the legal test was considered met by the court.

In respect of the second prong of "irreparable harm," Arysta successfully overcame this hurdle by putting forward a substantial record of evidence in support of its claim, including evidence from a private investigator about the financial circumstances of AgraCity (i.e. a substantial risk that AgraCity would not be able to pay a damages award if they were found liable for infringement at trial) and an expert's report on the economic impact AgraCity's generic product would have in respect of estimated financial losses to Arysta (i.e. estimated losses of $1.8 – $2.0 million by introduction of AgraCity's generic herbicide). Unfortunately for AgraCity, it did not provide nearly the same evidence in support of its opposition to the interim injunction, which weighed in favour of Arysta.

Finally, in respect of the third prong, the court was convinced that this was satisfied based on the facts before it. The court noted that in addition to "the expert evidence that the harm to [Arysta] through lost sales and other effects would be greater than the harm to AgraCity of a delay in launching its product" [75], AgraCity was given "notice from Arysta about its patents and its intention to enforce them," but AgraCity still "went ahead with its marketing and sales plans without taking any steps to "clear the way," either by challenging the validity of the patent or by seeking license from Arysta." Thus, the court felt that AgraCity "deliberately took the risk with its eyes open to the possible consequences" [79].

In satisfying all three steps of the legal test, the court granted the interim injunction requested by Arysta such that "AgraCity should not be allowed to launch its product at this time, pending a disposition of the interlocutory injunction or determination of the patent infringement action," thereby keeping AgraCity out of the market for the growing season [80].

Thus, this case reinforces that, despite the rarity of granting interlocutory or interim injunctions in Canada, a positive outcome in such cases may be possible if the patentee provides the court with "clear, convincing, and non-speculative evidence" by, for example, a detailed record of facts in support of harm to be suffered by the patentee by way of the infringement. Cases such as these provide incentive for patentees concerned about the possibility of enjoining alleged infringers prior to infringement proceedings, as well as for prospective patentees interested in filing patents in Canada and subsequently enforcing their patent rights.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Goldman Sloan Nash & Haber LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Goldman Sloan Nash & Haber LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions